Strauss, B <br/><br/>
Best hope or last hope: access to phase III clinical trials of HER-2/neu for advanced stage breast cancer patients.  [electronic resource] 

 -  Journal of advanced nursing  Feb 2000 
 - 259-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0309-2402 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2648.2000.01302.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase III as Topic--nursing<br/>Female<br/>Health Services Accessibility--standards<br/>Humans<br/>Neoplasm Staging<br/>Patient Selection<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins--immunology<br/>Receptor, ErbB-2--immunology<br/>Research Subjects